Attenuation of the severity of acute respiratory distress syndrome by pomiferin through blocking inflammation and oxidative stress in an akt/foxo1 pathway-dependent manner

HIGHLIGHTS

• who: Zheng Tang and collaborators from the Department of Thoracic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China have published the article: Attenuation of the Severity of Acute Respiratory Distress Syndrome by Pomiferin through Blocking Inflammation and Oxidative Stress in an AKT/Foxo1 Pathway-Dependent Manner, in the Journal: Oxidative Medicine and Cellular Longevity 6 of 26/Nov/2022
• what: Taken together the study showed that pomiferin could exert an ARDS-protective effect by blocking the AKT/Foxo1 signal pathway to inhibit LPS-induced inflammatory response and oxidative injury which may serve as a . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.